Micronuclei-based Model System Reveals Functional Consequences of Chromothripsis in Human Cells
Authors
Affiliations
Cancer cells often harbor chromosomes in abnormal numbers and with aberrant structure. The consequences of these chromosomal aberrations are difficult to study in cancer, and therefore several model systems have been developed in recent years. We show that human cells with extra chromosome engineered via microcell-mediated chromosome transfer often gain massive chromosomal rearrangements. The rearrangements arose by chromosome shattering and rejoining as well as by replication-dependent mechanisms. We show that the isolated micronuclei lack functional lamin B1 and become prone to envelope rupture, which leads to DNA damage and aberrant replication. The presence of functional lamin B1 partly correlates with micronuclei size, suggesting that the proper assembly of nuclear envelope might be sensitive to membrane curvature. The chromosomal rearrangements in trisomic cells provide growth advantage compared to cells without rearrangements. Our model system enables to study mechanisms of massive chromosomal rearrangements of any chromosome and their consequences in human cells.
Bokenkamp J, Keuper K, Redel S, Barthel K, Johnson L, Becker A EMBO J. 2025; .
PMID: 39930267 DOI: 10.1038/s44318-025-00372-w.
Acral Melanoma: A Review of Its Pathogenesis, Progression, and Management.
Kim S, Tsao H Biomolecules. 2025; 15(1).
PMID: 39858514 PMC: 11763010. DOI: 10.3390/biom15010120.
Origin of Chromosome 12 Trisomy Surge in Human Induced Pluripotent Stem Cells (iPSCs).
Narozna M, Latham M, Gorbsky G bioRxiv. 2024; .
PMID: 39677655 PMC: 11642788. DOI: 10.1101/2024.12.02.626470.
Microcell-mediated chromosome transfer between non-identical human iPSCs.
Uno N, Miyamoto H, Yamazaki K, Egawa M, Kobayashi H, Kazuki K Mol Ther Nucleic Acids. 2024; 35(4):102382.
PMID: 39634136 PMC: 11616053. DOI: 10.1016/j.omtn.2024.102382.
A TRilogy of ATR's Non-Canonical Roles Throughout the Cell Cycle and Its Relation to Cancer.
Joo Y, Ramirez C, Kabeche L Cancers (Basel). 2024; 16(20).
PMID: 39456630 PMC: 11506335. DOI: 10.3390/cancers16203536.